To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Durham, North Carolina-based Ribometrix, a biotechnology company developing small molecule therapeutics that directly target RNA to treat human diseases, has named Barclay Phillips as chief operating officer and chief financial officer.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Copyright PEI Media
Not for publication, email or dissemination